|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9911019280003321 |
|
|
Titolo |
Defining optimal immunotherapies for type 1 diabetes / / [editors: Gregory Bock and Jamie Goode] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London, : Novartis Foundation, 2008 |
|
|
|
|
|
|
|
ISBN |
|
9786611840525 |
9781281840523 |
1281840521 |
9780470697405 |
0470697407 |
9780470697412 |
0470697415 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (224 p.) |
|
|
|
|
|
|
Collana |
|
Novartis Foundation symposium ; ; v. 292 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Diabetes - Immunotherapy |
Diabetes - Treatment |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Defining Optimal Immunotherapies for Type 1 Diabetes; Contents; Participants; Chair's introduction; Pancreatic pathology in type 1 diabetes in human; The b cell population in type 1 diabetes; Bone marrow expressing a diabetes resistance MHC class II allele: diabetes deviation by chronic immune stimulation; Resuscitating adaptive Tregs with combination therapies?; Cytotoxic T cell mechanisms of b cell destruction in non-obese diabetic mice; Type 1 diabetes: chronic progressive autoimmune disease; Current and past prevention and intervention trials in type 1 diabetes |
CD8 and cytotoxic T cells in type 1 diabetesGeneral discussion I; General discussion II; Genetic and therapeutic control of diabetogenic CD8+ T cells; General discussion III; Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of b cell mass; Immune markers of disease and therapeutic intervention in type 1 diabetes; Re-establishing immune tolerance in type 1 diabetes via regulatory T cells; Translating mucosal antigen based prevention of |
|
|
|
|